Clinical trial
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
NCT03740256
Study timeline
Study start (actual)2020-12-14Date precision: day
Registry last updated2026-02-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Bladder Cancerunresolved
Head and Neck Squamous Cell Carcinomaunresolved
Cancer of the Salivary Glandunresolved
Lung Cancerunresolved
Breast Cancerunresolved
Gastric Cancerunresolved
Esophageal Cancerunresolved
Colorectal Cancerunresolved
Pancreatic Adenocarcinomaunresolved
Solid Tumorunresolved
Interventions
CAdVECBIOLOGICAL
Sponsors & collaborators
Baylor College of Medicinelead sponsor
The Methodist Hospital Research Institutecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03740256 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.